e-Drug3D 540 |
TRILOSTANE DISCONTINUED
|
cas 13647-35-3 |
CLASS HORMONE |
ROUTE (list) ORAL |
ATC code |
PK parameters |
Target TARGET 3-BETA-HYDROXYSTEROID DEHYDROGENASE |
DrugCentral 3 beta-hydroxysteroid dehydrogenase,Delta type 2 UNIPROT P26439 HSD3B2 |
Download SDF file | Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4.alpha.,5.alpha.,17.beta.)- Formula: Calculated chemical properties: MW 329.43 NB_atoms 24 XLogP 3.47 PSA 71.502 NB_HD 2 NB_HA 4 fsp3 0.85 Lipinski(0=no;1=yes) 1 |
FDA NDA 018719 (pdf not found) INN (TRILOSTANE) MODRASTANE (BIOENVISION) APPROVAL= AP YEAR= 1984 NEWMOLECULARENTITY DISCONTINUED |
Other links: |